Yes, Alzheimer’s disease is a type of dementia. Dementia itself is not a single disease but an umbrella term describing a range of symptoms that interfere with memory, thinking, and daily functioning. Alzheimer’s is the most common cause, accounting for 60% to 80% of all dementia cases.
What “Type of Dementia” Actually Means
Think of dementia the way you’d think of “heart disease.” Heart disease isn’t one condition. It’s a category that includes coronary artery disease, heart failure, arrhythmias, and others. Each has different causes and treatments, but they all affect the heart. Dementia works the same way: it’s a category of conditions that all impair cognitive function severely enough to disrupt everyday life. Alzheimer’s is one specific brain disease within that category.
This distinction matters because the cause of someone’s dementia changes what symptoms they experience first, how quickly the disease progresses, and what treatments might help. A person with Alzheimer’s has a fundamentally different disease process in their brain than someone with vascular dementia or Lewy body dementia, even though they may share some overlapping symptoms like memory loss or confusion.
What Makes Alzheimer’s Different From Other Dementias
Alzheimer’s disease is driven by two abnormal protein buildups in the brain: amyloid plaques and tau tangles. These toxic deposits damage and kill neurons over time, starting in areas responsible for memory and gradually spreading to regions that control language, reasoning, and sensory processing. The combination of amyloid and tau pathology is the hallmark that separates Alzheimer’s from other forms of dementia.
Other common dementias have distinct biological causes:
- Vascular dementia results from disrupted blood flow to the brain, often caused by blood clots or small strokes. Symptoms can appear suddenly after a vascular event rather than building slowly.
- Lewy body dementia involves abnormal deposits of a different protein, alpha-synuclein. It tends to cause visual hallucinations, sleep disorders, and movement problems like muscle rigidity early on, alongside cognitive decline.
- Frontotemporal dementia affects the frontal and temporal lobes first, causing personality changes, impulsive behavior, and language difficulties rather than the memory loss that typically signals Alzheimer’s.
Alzheimer’s almost always starts with memory. The earliest sign is usually difficulty forming new memories, like forgetting recent conversations or repeating the same questions. Other dementias often announce themselves differently: a Lewy body patient might first notice trouble concentrating or vivid hallucinations, while someone developing frontotemporal dementia might become emotionally flat or socially inappropriate before any memory problems appear.
How Alzheimer’s Progresses
Alzheimer’s moves through a long, gradual arc. Brain changes begin a decade or more before any noticeable symptoms, during what researchers call the preclinical stage. Amyloid plaques and tau tangles are already forming, but the person feels and functions normally.
By the mild stage, memory lapses become hard to ignore. People get lost in familiar places, have trouble managing finances, take longer to complete routine tasks, and may show personality shifts. This is when most people receive a diagnosis. The moderate stage brings more pronounced confusion, difficulty recognizing family and friends, problems with multistep tasks like getting dressed, and sometimes hallucinations or paranoia. In severe Alzheimer’s, communication becomes impossible. The person is fully dependent on others for care, and near the end, they may be bedridden as the body shuts down.
The total duration from diagnosis to death varies widely but typically spans 4 to 8 years, though some people live longer. The speed of progression depends on age at diagnosis, overall health, and individual biology.
Who Gets Alzheimer’s
About 1 in 9 Americans age 65 and older has Alzheimer’s, and the risk climbs steeply with age. Of the estimated 7.2 million Americans living with the disease in 2025, 74% are 75 or older. Age is the single biggest risk factor, though it’s not the only one. Family history, certain genetic variants, cardiovascular health, and lifestyle factors like physical activity and social engagement all influence risk.
Alzheimer’s is not a normal part of aging. Occasional forgetfulness, like misplacing your keys or blanking on a name, is common as you get older. Alzheimer’s is different: it’s a progressive disease that destroys brain tissue and steadily erodes the ability to function independently.
How Alzheimer’s Is Identified
For decades, diagnosing Alzheimer’s with certainty required examining brain tissue after death. That’s changed significantly. Doctors now use a combination of cognitive testing, brain imaging, and lab work to build a diagnosis during a person’s lifetime.
One of the most notable recent advances is blood testing. A 2024 study published in Nature Medicine found that a blood test measuring a specific form of a tau protein predicted Alzheimer’s brain pathology with 90% overall accuracy. The test had a 91% positive predictive value, meaning when it flagged someone as having Alzheimer’s pathology, it was right about 9 times out of 10. It also had an 89% negative predictive value, reliably identifying people who did not have the disease. These blood tests are not yet standard everywhere, but they represent a major shift toward earlier, less invasive detection.
Clinicians also now recognize that Alzheimer’s exists on a continuum. Before full dementia develops, many people pass through a stage called mild cognitive impairment, where thinking skills decline noticeably but daily functioning remains mostly intact. Not everyone with mild cognitive impairment progresses to Alzheimer’s, but it’s an important window for monitoring and, increasingly, for early intervention.
Why the Distinction Matters
Knowing that someone has Alzheimer’s specifically, rather than “dementia” generally, shapes the entire care plan. Treatments that target amyloid plaques, for example, would not help someone whose dementia is caused by blood vessel damage or alpha-synuclein deposits. Caregiving strategies also differ: a person with Lewy body dementia may react dangerously to certain medications commonly used for behavioral symptoms in Alzheimer’s, and someone with frontotemporal dementia may need entirely different behavioral support than an Alzheimer’s patient.
If you or someone close to you has been told they have dementia, it’s worth understanding the specific type. The label “dementia” tells you what’s happening. The specific diagnosis tells you why, and that’s what guides what comes next.